Repligen | RGEN - Trade Debtors


Repligen reported $151.55M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Agilent USD 1.52B 34M Dec/2025
Align Technology USD 1.13B 23.36M Mar/2026
Bio Techne USD 214.56M 29.95M Mar/2026
BioMarin Pharmaceutical USD 903.91M 4.3M Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Bruker USD 542.7M 2.2M Mar/2026
Charles River Laboratories USD 700.25M 727.92M Mar/2026
Danaher USD 4.76B 845M Mar/2026
Dentsply International USD 622M 66M Mar/2026
General Electric Aerospace USD 22.18B 6.89B Mar/2026
Henry Schein USD 1.72B 68M Mar/2026
Illumina USD 738M 116M Mar/2026
IQVIA Holdings USD 3.38B 52M Mar/2026
Mettler Toledo International USD 708.21M 70.04M Mar/2026
Myriad Genetics USD 115.3M 2.7M Dec/2025
OraSure Technologies USD 22.2M 2.1M Dec/2025
Pacific Biosciences Of California USD 35.45M 4.83M Dec/2025
Pfizer USD 16.17B 332M Mar/2026
Repligen USD 151.55M 7.03M Mar/2026
Revvity USD 691.38M 53.29M Mar/2026
Standard Biotools USD 13.43M 109K Dec/2025
Thermo Fisher Scientific USD 9.2B 304M Mar/2026
Waters USD 1.76B 930.16M Mar/2026
West Pharmaceutical Services USD 685.6M 111.2M Mar/2026